![John Öhd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Öhd
Directeur Général chez
MODUS THERAPEUTICS HOLDING AB
Profil
John Öhd currently works at Modus Therapeutics AB, as Chief Executive Officer, Modus Therapeutics Holding AB, as Chief Executive Officer from 2020, BOOST Pharma ApS, as Director from 2024, AnaCardio AB, as Director, Umecrine Cognition AB, as Director from 2020, SVF Vaccines AB, as Director from 2020, and KDventures AB, as Chief Scientific Officer & Venture Partner.
Dr. Öhd also formerly worked at Shire Sweden AB, as Senior Director-Experimental Medicine, AstraZeneca AB, as Group Director-Development from 2007 to 2012, and Medivir AB, as Chief Medical Officer from 2017 to 2018.
Dr. Öhd received his doctorate degree from the University of Linköping and doctorate degree from the University of Lund.
Postes actifs de John Öhd
| Sociétés | Poste | Début |
|---|---|---|
| KDVENTURES AB | Directeur Technique/Scientifique/R&D | 01/06/2020 |
| MODUS THERAPEUTICS HOLDING AB | Directeur Général | 01/01/2018 |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Directeur Général | - |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Directeur/Membre du Conseil | 01/10/2020 |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Directeur/Membre du Conseil | 01/10/2020 |
AnaCardio AB
 AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Directeur/Membre du Conseil | - |
Boostpharma ApS
 Boostpharma ApS BiotechnologyHealth Technology Develops a stem cell therapy for treatment of osteogenesis imperfecta | Directeur/Membre du Conseil | 01/06/2024 |
Anciens postes connus de John Öhd
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVIR AB | Directeur Technique/Scientifique/R&D | 15/07/2018 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/06/2012 |
| ░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de John Öhd
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Modus Therapeutics Holding AB
 Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease | Health Technology |
Svenska Vaccinfabriken Produktion AB
Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Health Technology |
Shire Sweden AB | |
Boostpharma ApS
Boostpharma ApS BiotechnologyHealth Technology Develops a stem cell therapy for treatment of osteogenesis imperfecta | Health Technology |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
